Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ramipril

An ACE inhibitor patented in 1981 and in use since 1989: it is a prodrug that the body converts into active ramiprilat, and is used for high blood pressure, heart failure and cardiovascular prevention. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines, other impurities and synthesis intermediates.

Did you know?It becomes active only when an enzyme, carboxylesterase 1, cuts off its ethyl ester group: this exposes a carboxylate that grips the zinc ion at the heart of the ACE enzyme.

RamiprilGo to the active ingredient →
RamiprilActive ingredientRamiprilCat. No. P-R011-001CAS 87333-19-5
Ramipril-d5Isotopically labelledRamipril-d5Cat. No. P-R011-026CAS 1132661-86-9

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Reference substanceRamipril CRSEDQM code R0145000Family Ramipril

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.